$ZYNE Plenty of time to get into Zynerba Pharma

Don't worry that you missed out on this initial move in the price, still plenty of room to run for ZYNERBA PHARMA, which specializes in the development and commercialism of cannabis treatments for conditions ranging from Epilepsy and Osteoarthritis. Although the stock has had a considerable move this month, it is still a low cap company with huge potential, so maybe no need to rush in but it is a long term investment, with a small allocation of capital for us.